Skip to content
A male scientist in protective glasses and a Johnson & Johnson lab coat writing on a clear whiteboard
HomeMedia Center

Media Center

Catch up on the latest Johnson & Johnson news and download the J&J logo and media assets here.

At Johnson & Johnson our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow. We will combine our science and technology with our determination to create a powerful force of care ... and profoundly impact health for humanity.

Highlighted press releases

Johnson & Johnson to Acquire Shockwave Medical

Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in Highest-Growth, Innovation-Oriented Segments of Cardiovascular Intervention Accelerates Sales Growth and Accretive to Operating Margin for Both Johnson & Johnson and Johnson & Johnson MedTech Conference Call at 8:30 a.m. ET To Discuss Details of the Transaction

Johnson & Johnson Reports Q1 2024 Results

2024 First-Quarter reported sales growth of 2.3% to $21.4 Billion with operational growth of 3.9%* and adjusted operational growth of 4.0%* · Adjusted operational growth excluding COVID-19 Vaccine of 7.7%* 2024 First-Quarter Earnings per share (EPS) increased to $2.20 and adjusted EPS increased to $2.71 or 12.4%* Company increasing the midpoint for Full-Year 2024 operational sales5 and adjusted operational EPS guidance

Johnson & Johnson Expands Commitment to Advance Health Equity in the United States

Johnson & Johnson supports more than 100 community-led organizations in marginalized communities to provide resources and tools to advance accessible, quality health care in the U.S.

Contact Global Media Relations

Journalists please use the following Johnson & Johnson media relations contacts for inquiries.

We recommend that if you are on deadline—or if it is after business hours—put ON DEADLINE in the subject of your email. It is also helpful if you are as specific as possible with your request.

Office Telephone: 732-524-1090
A person using their smartphone to view the Our Credo page on the Johnson & Johnson website

Media interviews

Johnson & Johnson has a state-of-the-art production studio available for media interviews. We have an HD-SDI fiber optic cable connection to the All Mobile Video Gateway in Weehawken, New Jersey. From All Mobile Video Gateway, we can be patched to just about anywhere in the United States accessible by fiber optic cable. Our studio can also send our signal to an AMV uplink which allows for international video connections.

All press releases

Press Releases


Sorry, I don't understand. Please try again

1,973 results
1,973 results

More information

Discover J&J

We are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow.

Latest news

Get the latest stories and press releases from Johnson & Johnson.

Our societal impact

We seek to provide solutions for some of the world’s most pressing global public health challenges.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.